Life sciences-focused medical equipment and services provider Monad said on Wednesday that it has pocketed 200 million yuan ($30 million) in a Series A round jointly led by state-owned investment firm Lucion and biotech company ABclonal
ABclonal is a China-based biotechnology company that researches and develops antibodies and molecular enzyme products for industries such as life science and pharmaceuticals.